Georg Maschmeyer
Impact in
- Infectious Diseases top 0.1%
- Antifungal resistance and susceptibility
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
Papers in
- Hematology 97
- Acute Myeloid Leukemia Research 71
- Oncology 101
- Neutropenia and Cancer Infections 79
- Co-authors
- Oliver A. Cornely (27 shared papers)Antje Haas (5 shared papers)Markus Ruhnke (20 shared papers)Wolfgang Hiddemann (34 shared papers)Dieter Buchheidt (24 shared papers)Hermann Einsele (14 shared papers)Dieter F. Hoelzer (6 shared papers)Johan A. Maertens (10 shared papers)
- Journals
- Blood (37 papers)Annals of Hematology (31 papers)Annals of Oncology (15 papers)Journal of Antimicrobial Chemotherapy (11 papers)Leukemia (7 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Georg Maschmeyer
254 papers receiving 17.7k citations
Georg Maschmeyer's Hit Papers
Peers
Comparison fields: 5 of 140
- Infectious Diseases 7.3k
- Hematology 2.9k
- Oncology 5.0k
- Epidemiology 6.2k
- Pathology and Forensic Medicine 2.7k
Countries citing papers authored by Georg Maschmeyer
This map shows the geographic impact of Georg Maschmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Maschmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Maschmeyer more than expected).
Fields of papers citing papers by Georg Maschmeyer
This network shows the impact of papers produced by Georg Maschmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Maschmeyer. The network helps show where Georg Maschmeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Georg Maschmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 278 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Hit paper breakdown → | 2008 | 4304 |
| 2 | Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium Hit paper breakdown → | 2019 | 1216 |
| 3 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial Hit paper breakdown → | 2013 | 1179 |
| 4 | Management of febrile neutropaenia: ESMO Clinical Practice Guidelines Hit paper breakdown → | 2016 | 533 |
| 5 | Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies Hit paper breakdown → | 2012 | 416 |
| 6 | 2016 | 335 | |
| 7 | 2007 | 313 | |
| 8 | Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network Hit paper breakdown → | 2016 | 313 |
| 9 | 2008 | 281 | |
| 10 | 2017 | 270 | |
| 11 | 1999 | 264 | |
| 12 | 2017 | 242 | |
| 13 | 1996 | 238 | |
| 14 | 2016 | 230 | |
| 15 | 2003 | 183 | |
| 16 | 2018 | 179 | |
| 17 | 2017 | 177 | |
| 18 | 2009 | 165 | |
| 19 | 2000 | 160 | |
| 20 | 2016 | 159 |
About Georg Maschmeyer
Georg Maschmeyer is a scholar working on Hematology, Oncology, Infectious Diseases, Epidemiology and Genetics, having authored 278 papers that have together received 18.3k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (79 papers), Acute Myeloid Leukemia Research (71 papers), Antifungal resistance and susceptibility (60 papers), Fungal Infections and Studies (47 papers), Acute Lymphoblastic Leukemia research (35 papers), Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). The work is most often cited by research in Infectious Diseases (7.3k citations), Hematology (2.9k citations), Oncology (5.0k citations), Epidemiology (6.2k citations) and Pathology and Forensic Medicine (2.7k citations). Georg Maschmeyer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Oliver A. Cornely, Antje Haas, Markus Ruhnke, Wolfgang Hiddemann, Dieter Buchheidt, Hermann Einsele, Dieter F. Hoelzer, Johan A. Maertens, Olaf Penack and Gerhard Heil. Their work appears in journals such as Blood, Annals of Hematology, Annals of Oncology, Journal of Antimicrobial Chemotherapy and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.